Identifying accurate biomarkers of cognitive decline is essential for advancing early diagnosis and prevention therapies in Alzheimer’s disease. The Alzheimer’s disease DREAM Challenge was designed as a computational crowdsourced project to benchmark the current state-of-the-art in predicting cognitive outcomes in Alzheimer’s disease based on high dimensional, publicly available genetic and structural imaging data. This meta-analysis failed to identify a meaningful predictor developed from either data modality, suggesting that alternate approaches should be considered for to prediction of cognitive performance.
from Dementia Big http://ift.tt/1YqB5BW
via Stopping Dementia
from WordPress http://ift.tt/22q7UAc
via alcoholic dementia
http://ift.tt/25VSxE6
No comments:
Post a Comment